(S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (ADJP (RB molecularly) (VBN targeted)) (NN drug) (NNS perturbations)) (PP (IN on) (NP (JJ cellular) (NNS activities) (CC and) (NNS fates)))))) (VP (VBP are) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB predict) (S (VP (VBG using) (NP (NN intuition)) (PP (ADVP (RB alone)) (IN because) (IN of) (NP (NP (DT the) (JJ complex) (NNS behaviors)) (PP (IN of) (NP (JJ cellular) (JJ regulatory) (NNS networks)))))))))))) (. .))
(S (NP (NP (DT An) (NN approach)) (PP (IN to) (S (VP (VBG overcoming) (NP (DT this) (NN problem)))))) (VP (VBZ is) (S (VP (TO to) (VP (VB develop) (NP (JJ mathematical) (NNS models)) (PP (IN for) (S (VP (VBG predicting) (NP (NN drug) (NNS effects))))))))) (. .))
(S (NP (PDT Such) (DT an) (NN approach)) (VP (VBZ beckons) (PP (IN for) (NP (NP (NN co-development)) (PP (IN of) (NP (JJ computational) (NNS methods))))) (PP (IN for) (S (VP (VP (VBG extracting) (NP (NNS insights)) (S (ADJP (JJ useful))) (PP (IN for) (NP (VBG guiding) (NN therapy) (NN selection)))) (CC and) (VP (VBG optimizing) (NP (NN drug) (NN scheduling))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP present) (CC and) (VBP evaluate) (NP (NP (DT a) (JJ generalizable) (NN strategy)) (PP (IN for) (S (VP (VBG identifying) (NP (NP (NN drug) (NN dosing) (NNS schedules)) (SBAR (WHNP (WDT that)) (S (VP (VBP minimize) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN drug)) (VP (VBN needed) (S (VP (TO to) (VP (VB achieve) (NP (NP (NP (VBN sustained) (NN suppression) (CC or) (NN elevation)) (PP (IN of) (NP (DT an) (JJ important) (JJ cellular) (NN activity) (HYPH /) (NN process)))) (, ,) (NP (NP (DT the) (NN recycling)) (PP (IN of) (NP (JJ cytoplasmic) (NNS contents)))))))))))))))) (PP (IN through) (NP (-LRB- -LRB-) (NN macro) (-RRB- -RRB-) (NN autophagy)))))))) (. .))
(S (NP (NP (JJ Therapeutic) (NN targeting)) (PP (IN of) (NP (NN autophagy)))) (VP (VBZ is) (ADVP (RB currently)) (VP (VBG being) (VP (VBN evaluated) (PP (PP (IN in) (NP (JJ diverse) (JJ clinical) (NNS trials))) (CC but) (PP (IN without) (NP (NP (DT the) (NN benefit)) (PP (IN of) (NP (DT a) (NML (NN control) (NN engineering)) (NN perspective))))))))) (. .))
(S (S (VP (VBG Using) (NP (NP (NP (DT a) (JJ nonlinear) (JJ ordinary) (JJ differential) (NN equation)) (-LRB- -LRB-) (NP (NN ODE)) (-RRB- -RRB-)) (NN model) (SBAR (WHNP (WDT that)) (S (VP (VBZ accounts) (PP (IN for) (NP (ADJP (VBG activating) (CC and) (VBG inhibiting)) (NNS influences))))))) (PP (IN among) (NP (NP (NML (NN protein) (CC and) (NN lipid)) (NNS kinases)) (SBAR (WHNP (WDT that)) (S (VP (VBP regulate) (NP (NP (NP (NN autophagy)) (-LRB- -LRB-) (NP (NN MTORC1) (, ,) (NN ULK1) (, ,) (NN AMPK) (CC and) (NN VPS34)) (-RRB- -RRB-)) (CC and) (NP (NP (NNS methods)) (VP (VBN guaranteed) (S (VP (TO to) (VP (VB find) (NP (ADJP (RB locally) (JJ optimal)) (NN control) (NNS strategies))))))))))))))) (, ,) (NP (PRP we)) (VP (VBP find) (NP (NP (NP (JJ optimal) (NN drug) (NN dosing) (NNS schedules)) (-LRB- -LRB-) (NP (NML (JJ open) (HYPH -) (NN loop)) (NNS controllers)) (-RRB- -RRB-)) (PP (IN for) (NP (NP (DT each)) (PP (IN of) (NP (NP (CD six) (NNS classes)) (PP (IN of) (NP (NML (NNS drugs) (CC and) (NN drug)) (NNS pairs))))))))) (. .))
(S (NP (PRP$ Our) (NN approach)) (VP (VBZ is) (NP (NP (ADJP (ADJP (JJ generalizable) (PP (IN to) (S (VP (VBG designing) (NP (NN monotherapy)))))) (CC and) (ADJP (JJ multi))) (NN therapy) (NN drug) (NNS schedules)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NP (JJ different) (NML (NN cell) (NN signaling)) (NNS networks)) (PP (IN of) (NP (NN interest))))))))) (. .))
